European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Experience with Advanced/Metastatic Epithelioid Sarcoma Patients Treated in Prospective Trials: Clinical Profile and Response to Systemic Therapy.

[1]  A. Italiano,et al.  Phase 2 multicenter study of the EZH2 inhibitor tazemetostat in adults with synovial sarcoma (NCT02601950). , 2017 .

[2]  J. Blay,et al.  A phase IIb multicentre study comparing the efficacy of trabectedin to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma: the TRUSTS trial. , 2015, European Journal of Cancer.

[3]  P. Reichardt,et al.  Gemcitabine and Docetaxel for Epithelioid Sarcoma: Results from a Retrospective, Multi-Institutional Analysis , 2014, Oncology.

[4]  J. Blay,et al.  Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. , 2014, The Lancet. Oncology.

[5]  Robin L. Jones,et al.  Role of Palliative Chemotherapy in Advanced Epithelioid Sarcoma , 2012, American journal of clinical oncology.

[6]  J. Blay,et al.  Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial , 2012, The Lancet.

[7]  Patrick Schöffski,et al.  Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 62043). , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  P. D. Dal Cin,et al.  Loss of INI1 Expression is Characteristic of Both Conventional and Proximal-type Epithelioid Sarcoma , 2009, The American journal of surgical pathology.

[9]  S. Scully,et al.  Prognostic Factors for Survival in Patients with Epithelioid Sarcoma: 441 Cases from the SEER Database , 2009, Clinical orthopaedics and related research.

[10]  D. Flum,et al.  Epithelioid sarcoma: the University of Washington experience. , 2008, American journal of surgery.

[11]  A. Ferrari,et al.  Epithelioid sarcoma in children and adolescents , 2006, Cancer.

[12]  M. Ballo,et al.  Epithelioid sarcoma: results of conservative surgery and radiotherapy. , 2001, International journal of radiation oncology, biology, physics.

[13]  Jonathan J. Lewis,et al.  Epithelioid sarcoma: Clinical behavior and prognostic factors of survival , 1997, Annals of Surgical Oncology.

[14]  J. Dobyns,et al.  Epithelioid sarcoma. An analysis of fifty-one cases. , 1988, The Journal of bone and joint surgery. American volume.

[15]  F. Enzinger,et al.  Epithelioid sarcoma: Diagnosis, prognostic indicators, and treatment *' † , 1985, The American journal of surgical pathology.

[16]  H. Suit,et al.  Radiation therapy of epithelioid sarcoma , 1983, Cancer.

[17]  F. Enzinger.  Epithelioid sarcoma. A sarcoma simulating a granuloma or a carcinoma , 1970 .

[18]  M. Boeri,et al.  Prognostic determinants in epithelioid sarcoma. , 2011, European journal of cancer.

[19]  F. Collin,et al.  A Clinicopathologic and Immunohistochemical Analysis of 106 Cases From the French Sarcoma Group , 2009 .

[20]  L. Schwartz,et al.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.

[21]  A. J. S. Fracs,et al.  Epithelioid sarcoma: the clinicopathological complexities of this rare soft tissue sarcoma , 2006, Annals of Surgical Oncology.

[22]  C. Fisher,et al.  Treatment of Epithelioid Sarcoma at the Royal Marsden Hospital , 2003, Sarcoma.

[23]  F. Mertens,et al.  World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone , 2002 .